+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Extracorporeal CO2 Removal Devices Market by Product (Disposables, Extracorporeal CO2 Machines), Access (Arteriovenous, Venovenous), Application, End-use - Forecast 2024-2030

  • PDF Icon

    Report

  • 189 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 5674640
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Extracorporeal CO2 Removal Devices Market size was estimated at USD 92.68 million in 2023, USD 104.73 million in 2024, and is expected to grow at a CAGR of 13.39% to reach USD 223.40 million by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Extracorporeal CO2 Removal Devices Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Extracorporeal CO2 Removal Devices Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Extracorporeal CO2 Removal Devices Market, highlighting leading vendors and their innovative profiles. These include Aferetica Srl, ALung Technologies, Inc. by LivaNova PLC, Baxter International Inc., Estor S.p.A, Getinge AB, Hemovent GmbH, Medica S.p.A, Medtronic PLC, and XENIOS AG by Fresenius Medical Care AG & Co. KGaA.

Market Segmentation & Coverage

This research report categorizes the Extracorporeal CO2 Removal Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Disposables
    • Extracorporeal CO2 Machines
  • Access
    • Arteriovenous
    • Venovenous
  • Application
    • Acute Respiratory Distress Syndrome
    • Bridge to Lung Transplant
    • Chronic Obstructive Pulmonary Disease
  • End-use
    • Ambulatory Surgical Centers
    • Clinics
    • Hospitals
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as

  1. What is the market size and forecast of the Extracorporeal CO2 Removal Devices Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Extracorporeal CO2 Removal Devices Market?
  3. What are the technology trends and regulatory frameworks in the Extracorporeal CO2 Removal Devices Market?
  4. What is the market share of the leading vendors in the Extracorporeal CO2 Removal Devices Market?
  5. Which modes and strategic moves are suitable for entering the Extracorporeal CO2 Removal Devices Market?

Additional Product Information:

  • The purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report
  • With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase
  • Purchase of this report includes 1 year online access with quarterly updates
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website

Additional Product Information:

  • The purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report
  • With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase
  • Purchase of this report includes 1 year online access with quarterly updates
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Extracorporeal CO2 Removal Devices Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising prevalence of acute respiratory failure, severe asthma, and COPD
5.1.1.2. Increasing regulatory product approval and clinical trials for the device
5.1.1.3. Growing healthcare infrastructure and rise in per capita expenditure
5.1.2. Restraints
5.1.2.1. High costs of extracorporeal CO2 removal devices
5.1.3. Opportunities
5.1.3.1. Technological advancements in extracorporeal CO2 removal devices
5.1.3.2. Emerging research & studies regarding the devices’ usage for other disorders
5.1.4. Challenges
5.1.4.1. Side effects of the application of extracorporeal CO2 removal devices
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Extracorporeal CO2 Removal Devices Market, by Product
6.1. Introduction
6.2. Disposables
6.3. Extracorporeal CO2 Machines
7. Extracorporeal CO2 Removal Devices Market, by Access
7.1. Introduction
7.2. Arteriovenous
7.3. Venovenous
8. Extracorporeal CO2 Removal Devices Market, by Application
8.1. Introduction
8.2. Acute Respiratory Distress Syndrome
8.3. Bridge to Lung Transplant
8.4. Chronic Obstructive Pulmonary Disease
9. Extracorporeal CO2 Removal Devices Market, by End-use
9.1. Introduction
9.2. Ambulatory Surgical Centers
9.3. Clinics
9.4. Hospitals
10. Americas Extracorporeal CO2 Removal Devices Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Extracorporeal CO2 Removal Devices Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Extracorporeal CO2 Removal Devices Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player
14. Competitive Portfolio
14.1. Key Company Profiles
14.1.1. Aferetica Srl
14.1.2. ALung Technologies, Inc. by LivaNova PLC
14.1.3. Baxter International Inc.
14.1.4. Estor S.p.A
14.1.5. Getinge AB
14.1.6. Hemovent GmbH
14.1.7. Medica S.p.A
14.1.8. Medtronic PLC
14.1.9. XENIOS AG by Fresenius Medical Care AG & Co. KGaA
14.2. Key Product Portfolio
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing
List of Figures
FIGURE 1. EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET RESEARCH PROCESS
FIGURE 2. EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, 2023 VS 2030
FIGURE 3. EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET DYNAMICS
FIGURE 7. EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 8. EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2023 VS 2030 (%)
FIGURE 10. EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 12. EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
FIGURE 14. EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 24. EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SHARE, BY KEY PLAYER, 2023

Companies Mentioned

  • Aferetica Srl
  • ALung Technologies, Inc. by LivaNova PLC
  • Baxter International Inc.
  • Estor S.p.A
  • Getinge AB
  • Hemovent GmbH
  • Medica S.p.A
  • Medtronic PLC
  • XENIOS AG by Fresenius Medical Care AG & Co. KGaA

Methodology

Loading
LOADING...

Table Information